Related Experiment Video
Updated: Sep 27, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Is mass screening enough to control tuberculosis in Ecuador's prisons?
I Valcárcel-Pérez1, J L Molina1, Z Fuentes2
1Autonomous. University of Barcelona. Barcelona.Spain.
Mass tuberculosis screening in Ecuador
Area of Science:
- Public Health
- Infectious Disease Epidemiology
- Prison Health
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in congregate settings like prisons.
- Ecuadorian prisons face unique challenges in controlling infectious diseases due to population density and healthcare access.
Purpose of the Study:
- To assess the effectiveness of mass screening campaigns for tuberculosis (TB) among inmates in Ecuadorian prisons.
- To determine the prevalence and identify risk factors associated with TB in this population.
Main Methods:
- A cross-sectional study involving 12,365 inmates entering two Ecuadorian prisons from January to December 2016.
- Analysis of chronic cough (CC) prevalence, TB positivity rates, and time distribution of cases.
- Logistic regression used to identify factors influencing TB positivity.
Main Results:
- A high prevalence of TB was found, with 1,332 chronic coughers identified and a TB positivity rate of 17.3%.
- The overall TB prevalence was 1.9%, with significant variation in detection and diagnosis over time.
- Higher prison density was associated with increased TB positivity (adjusted OR 3.8).
Conclusions:
- Mass TB screening alone is insufficient to control tuberculosis in Ecuadorian prisons.
- The high incidence necessitates strengthening diagnostic processes to interrupt transmission chains.
- Targeted interventions considering prison density are crucial for effective TB control.
More Related Videos
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: